Provided by: Biolocity
Who’s eligible: Innovators – inside and outside Emory and Georgia Tech – who are developing health security technologies
In 2019, Biolocity was selected as one of 13 sites in BARDA’s DRIVe Accelerator Network to:
- identify inventors whose ideas have the potential to transform emergency preparedness, detection and response
- connect these inventors with resources that will enable earlier treatment and warning for communities against outbreaks.
DRIVE partners with companies and teams that offer solutions to a broad range of national health security threats. One of DRIVe’s two main solicitations is called EZ-BAA funding (for awards under $749K).
The Biolocity team helps potential applicants submit a robust and on-target proposal. If you’re interested in learning how we can help with your submission, please request a technology review meeting. The meetings are open to life science entrepreneurs both inside and outside of Emory University and Georgia Tech.
Current areas of interest for EZ-BAA funding applications:
- Early Notification to Act, Control and Treat (ENACT) aims to provide actionable health information to individuals and medical care providers in early stages of an infection, ideally before noticeable symptoms.
- Solving Sepsis: innovative technological approaches to empower both the patient and the healthcare provider.
- ReDIRECT (Repurposing Drugs In Response to Chemical Threats) aims to repurpose commonly available therapeutics that can treat the symptoms associated with chemical agent exposure.
- Beyond the Needle (Alternative Routes of Administration for Vaccines) to make vaccinations easier to administer and more widely available.
- ImmuneChip+ (Advanced Microphysiological Immune Tissue Platforms)